FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Val J. Lowe

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
Trond Velde Bogsrud; Dimitrios Karantanis; Mark A Nathan; Brian P Mullan; Gregory A Wiseman; Jan L Kasperbauer; Carl C Reading; Trine Björo; Ian D Hay; Val J. Lowe
The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma.
Dimitrios Karantanis; Jolanta M Durski; Val J. Lowe; Mark A Nathan; Brian P Mullan; Evangelos Georgiou; Patrick B Johnston; Gregory A Wiseman
18F-FDG PET and PET/CT in Burkitt's lymphoma.
Abdollah Behzadi; Yee Ung; Val J. Lowe; Claude Deschamps
The role of positron emission tomography in the management of non-small cell lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Val J. Lowe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Trond Velde Bogsrud; Dimitrios Karantanis; Mark A Nathan; Brian P Mullan; Gregory A Wiseman; Jan L Kasperbauer; Carl C Reading; Trine Björo; Ian D Hay; Val J. Lowe
The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2010;12(5):547-53.
2010: Dimitrios Karantanis; Jolanta M Durski; Val J. Lowe; Mark A Nathan; Brian P Mullan; Evangelos Georgiou; Patrick B Johnston; Gregory A Wiseman
18F-FDG PET and PET/CT in Burkitt's lymphoma.
European journal of radiology 2010;75(1):e68-73.
2009: Abdollah Behzadi; Yee Ung; Val J. Lowe; Claude Deschamps
The role of positron emission tomography in the management of non-small cell lung cancer.
Canadian journal of surgery. Journal canadien de chirurgie 2009;52(3):235-42.
2009: Bryan J Krajicek; Jay H Ryu; Thomas E Hartman; Val J. Lowe; Robert Vassallo
Abnormal fluorodeoxyglucose PET in pulmonary Langerhans cell histiocytosis.
Chest 2009;135(6):1542-9.
2009: Val J. Lowe; Brad J Kemp; Clifford R Jack; Matthew Senjem; Stephen D Weigand; Maria M Shiung; Glenn Smith; David S. Knopman; Bradley Boeve; Brian P Mullan; Ronald C. Petersen
Comparison of 18F-FDG and PiB PET in cognitive impairment.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(6):878-86.
2009: Clifford R Jack; Val J. Lowe; Stephen D Weigand; Heather J Wiste; Matthew L Senjem; David S. Knopman; Maria M Shiung; Jeffrey L Gunter; Bradley Boeve; Brad J Kemp; Michael Weiner; Ronald C. Petersen
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.
Brain : a journal of neurology 2009;132(Pt 5):1355-65.
2009: Brad J Kemp; Carrie B Hruska; Aaron R McFarland; Mark W Lenox; Val J. Lowe
NEMA NU 2-2007 performance measurements of the Siemens Inveon preclinical small animal PET system.
Physics in medicine and biology 2009;54(8):2359-76.
2009: Eric L Matteson; Val J. Lowe; F G Prendergast; Cynthia S Crowson; Kevin G Moder; David Morgenstern; R A Messmann; P S Low
Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan.
Clinical and experimental rheumatology 2009;27(2):253-9.
2009: Harry H Yoon; Val J. Lowe; Stephen D Cassivi; Yvonne Romero
The role of FDG-PET and staging laparoscopy in the management of patients with cancer of the esophagus or gastroesophageal junction.
Gastroenterology clinics of North America 2009;38(1):105-20, ix.
2009: Robert Murphy; Kirk M Doerger; Mark A Nathan; Val J. Lowe
Pretreatment with diphenoxylate hydrochloride/atropine sulfate (Lomotil) does not decrease physiologic bowel FDG activity on PET/CT scans of the abdomen and pelvis.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2009;11(2):114-7.
2008: Daniel L Fortes; Mark S Allen; Val J. Lowe; Dennis Wigle; Stephen D Cassivi; Francis C Nichols; Keh-Hsien Robert Shen; Claude Deschamps
The sensitivity of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of metastatic pulmonary nodules.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2008;34(6):1223-7.
2008: Rajesh R Patel; Rathan M Subramaniam; Jayawant N Mandrekar; Julie E Hammack; Val J. Lowe; James R Jett
Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis.
Mayo Clinic proceedings. Mayo Clinic 2008;83(8):917-22.
2008: Trond Velde Bogsrud; Dimitrios Karantanis; Mark A Nathan; Brian P Mullan; Gregory A Wiseman; Jan L Kasperbauer; Carl C Reading; Ian D Hay; Val J. Lowe
18F-FDG PET in the management of patients with anaplastic thyroid carcinoma.
Thyroid : official journal of the American Thyroid Association 2008;18(7):713-9.
2008: David M Atkinson; Michelle Clarke; Ann C Mladek; Brett L Carlson; David P Trump; Mark S Jacobson; Brad J Kemp; Val J. Lowe; Jann N. Sarkaria
Using fluorodeoxythymidine to monitor anti-EGFR inhibitor therapy in squamous cell carcinoma xenografts.
Head & neck 2008;30(6):790-9.
2008: Evanthia C Galanis; Stephanie K Carlson; Nathan R Foster; Val J. Lowe; Fernando Quevedo; Robert R McWilliams; Axel Grothey; Aminah Jatoi; Steven R Alberts; Joseph Rubin
Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer.
Molecular therapy : the journal of the American Society of Gene Therapy 2008;16(5):979-84.
2008: David Dingli; Val J. Lowe
Plasma membrane phospholipid labeling to estimate tumor burden and kinetics.
Cancer biology & therapy 2008;7(5):748-9.
2008: Dimitrios Karantanis; Rathan M Subramaniam; Patrick J Peller; Val J. Lowe; Jolanta M Durski; Douglas A Collins; Evangelos Georgiou; Stephen M Ansell; Gregory A Wiseman
The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma.
Clinical lymphoma & myeloma 2008;8(2):94-9.
2008: James W Fletcher; Benjamin Djulbegovic; Heloisa P Soares; Barry A Siegel; Val J. Lowe; Gary H Lyman; R Edward Coleman; Richard L Wahl; John Christopher Paschold; Norbert Avril; Lawrence H Einhorn; W Warren Suh; David Samson; Dominique Delbeke; Mark Gorman; Anthony F Shields
Recommendations on the use of 18F-FDG PET in oncology.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(3):480-508.
2008: Clifford R Jack; Val J. Lowe; Matthew L Senjem; Stephen D Weigand; Brad J Kemp; Maria M Shiung; David S. Knopman; Bradley Boeve; William E Klunk; Chester A Mathis; Ronald C. Petersen
11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.
Brain : a journal of neurology 2008;131(Pt 3):665-80.
2008: James W Fletcher; Steven M Kymes; Michael Gould; Naomi Alazraki; R Edward Coleman; Val J. Lowe; Charles Marn; George Segall; Lyn A Thet; Kelvin Lee
A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(2):179-85.
2008: Stephanie A Shintani; Robert L Foote; Val J. Lowe; Paul D Brown; Yolanda I Garces; Jan L Kasperbauer
Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancer.
International journal of radiation oncology, biology, physics 2008;70(2):322-9.
2007: Dimitrios Karantanis; Brian P O'eill; Rathan M Subramaniam; Robert J Witte; Brian P Mullan; Mark A Nathan; Val J. Lowe; Patrick J Peller; Gregory A Wiseman
18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients.
Nuclear medicine communications 2007;28(11):834-41.
2007: Dimitrios Karantanis; Trond Velde Bogsrud; Gregory A Wiseman; Brian P Mullan; Rathan M Subramaniam; Mark A Nathan; Patrick J Peller; Rebecca S Bahn; Val J. Lowe
Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(6):896-901.
2007: Trond Velde Bogsrud; Dimitrios Karantanis; Mark A Nathan; Brian P Mullan; Gregory A Wiseman; Douglas A Collins; Jan L Kasperbauer; Scott E Strome; Carl C Reading; Ian D Hay; Val J. Lowe
The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
Nuclear medicine communications 2007;28(5):373-81.
2007: Craig E Daniels; Val J. Lowe; Marie-Christine Aubry; Mark S Allen; James R Jett
The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
Chest 2007;131(1):255-60.
2006: Brad J Kemp; Chang Kim; John J Williams; Alexander Ganin; Val J. Lowe
NEMA NU 2-2001 performance measurements of an LYSO-based PET/CT system in 2D and 3D acquisition modes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(12):1960-7.
2006: Helen Karakelides; Val J. Lowe; Dana Erickson
Visual vignette.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2006;12(6):699.
2006: Jared A Christensen; Mark A Nathan; Brian P Mullan; Thomas E Hartman; Stephen J Swensen; Val J. Lowe
Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
AJR. American journal of roentgenology 2006;187(5):1361-7.
2006: Stephanie K Carlson; Kelly L Classic; Elizabeth M Hadac; Claire E Bender; Brad J Kemp; Val J. Lowe; Tanya L Hoskin; stephen russell
In vivo quantitation of intratumoral radioisotope uptake using micro-single photon emission computed tomography/computed tomography.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2006;8(6):324-32.
2006: Trond Velde Bogsrud; Dimitrios Karantanis; Val J. Lowe
Normal uptake of F-18 FDG in the sublingual gland.
Clinical nuclear medicine 2006;31(1):50.
2006: David Dingli; Brad J Kemp; Michael K O'Connor; John C Morris; stephen russell; Val J. Lowe
Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2006;8(1):16-23.
2005: Val J. Lowe; Fargol Booya; Joel G Fletcher; Mark Nathan; Eric Jensen; Brian Mullan; Eric Rohren; Maurits J Wiersema; Enrique Vazquez-Sequeiros; Joseph A Murray; Mark S Allen; Michael J Levy; Jonathan E Clain
Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2005;7(6):422-30.
2005: Rebecca M Lindell; Thomas E Hartman; Stephen J Swensen; James R Jett; David E Midthun; Mark A Nathan; Val J. Lowe
Lung cancer screening experience: a retrospective review of PET in 22 non-small cell lung carcinomas detected on screening chest CT in a high-risk population.
AJR. American journal of roentgenology 2005;185(1):126-31.
2005: Eric L Matteson; Hyon K Choi; Dennis S Poe; Christopher Wise; Val J. Lowe; Thomas J McDonald; Mahboob U Rahman
Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study.
Arthritis and rheumatism 2005;53(3):337-42.
2004: Eric M Rohren; Val J. Lowe
Update in PET imaging of nonsmall cell lung cancer.
Seminars in nuclear medicine 2004;34(2):134-53.
2004: R Houston Thompson; Robert P Hartman; Val J. Lowe; Akira Kawashima; Bradley C Leibovich
Applications of positron emission tomography imaging, intraoperative ultrasonography, magnetic resonance imaging, and angiography in the evaluation of renal masses.
Current urology reports 2004;5(1):30-4.
2004: Brendan C Stack; Christopher Hollenbeak; Christopher M Lee; Frank Dunphy; Val J. Lowe; Paul D Hamilton
Metallopanstimulin as a marker for head and neck cancer.
World journal of surgical oncology 2004;2():45.
2003: Scott W Fosko; Weimin Hu; Thomas F Cook; Val J. Lowe
Positron emission tomography for basal cell carcinoma of the head and neck.
Archives of dermatology 2003;139(9):1141-6.
2003: Val J. Lowe; Brian P Mullan; Ian D Hay; Bryan McIver; Jan L Kasperbauer
18F-FDG PET of patients with Hürthle cell carcinoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(9):1402-6.
2003: Val J. Lowe
Positron emission tomography scanning in lung cancer.
Respiratory care clinics of North America 2003;9(1):119-36.
2003: Sharon M Hamblen; Val J. Lowe
Clinical 18F-FDG oncology patient preparation techniques.
Journal of nuclear medicine technology 2003;31(1):3-7; quiz 8-10.
2003: Mehrdad Mazlumzadeh; Val J. Lowe; Brian P Mullan; David Fabry; Thomas J McDonald; Eric L Matteson
The utility of positron emission tomography in the evaluation of autoimmune hearing loss.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2003;24(2):201-4.
2002: Scott H Hardeman; Brian Collins; Val J. Lowe; Harvey Solomon; Brendan C Stack
Cholangiocarcinoma metastatic to the neck: first report of a case.
Ear, nose, & throat journal 2002;81(11):776-8.
2002: Val J. Lowe; Gregory A Wiseman
Assessment of Lymphoma Therapy Using (18)F-FDG PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(8):1028-30.
2002: Lee A Forstrom; W L Dunn; Brian P Mullan; Joseph C Hung; Val J. Lowe; LM Thorson
Biodistribution and dosimetry of [(18)F]fluorodeoxyglucose labelled leukocytes in normal human subjects.
Nuclear medicine communications 2002;23(8):721-5.
2002: Val J. Lowe; Brendan C Stack
Esophageal cancer and head and neck cancer.
Seminars in roentgenology 2002;37(2):140-50.
2002: Pond R Kelemen; Val J. Lowe; Nancy Phillips
Positron emission tomography and sentinel lymph node dissection in breast cancer.
Clinical breast cancer 2002;3(1):73-7.
2002: Kitti Kaiboriboon; Val J. Lowe; Sunanta I Chantarujikapong; R Edward Hogan
The usefulness of subtraction ictal SPECT coregistered to MRI in single- and dual-headed SPECT cameras in partial epilepsy.
Epilepsia 2002;43(4):408-14.
2001: Christopher Hollenbeak; Val J. Lowe; Brendan C Stack
The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck.
Cancer 2001;92(9):2341-8.
2001: Mimi S Kokoska; G Olson; P R Kelemen; Scott W Fosko; Frank Dunphy; Val J. Lowe; Brendan C Stack
The use of lymphoscintigraphy and PET in the management of head and neck melanoma.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2001;125(3):213-20.
2000: Lee A Forstrom; Brian P Mullan; Joseph C Hung; Val J. Lowe; LM Thorson
18F-FDG labelling of human leukocytes.
Nuclear medicine communications 2000;21(7):691-4.
2000: M A Khan; C S Combs; Elizabeth M Brunt; Val J. Lowe; Michael K Wolverson; Harvey Solomon; Brian T Collins; Adrian M Di Bisceglie
Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.
Journal of hepatology 2000;32(5):792-7.
2000: Brendan C Stack; Val J. Lowe; Scott H Hardeman
Radioguided surgical advancements for head and neck oncology.
Southern medical journal 2000;93(4):360-3.
2000: Val J. Lowe; James H Boyd; Frank Dunphy; H Kim; Teresa L Dunleavy; Brian T Collins; D Martin; B C Stack; C Hollenbeak; JW Fletcher
Surveillance for recurrent head and neck cancer using positron emission tomography.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(3):651-8.
2000: Brian T Collins; Val J. Lowe; Frank Dunphy
Initial evaluation of pulmonary abnormalities: CT-guided fine-needle aspiration biopsy and fluoride-18 fluorodeoxyglucose positron emission tomography correlation.
Diagnostic cytopathology 2000;22(2):92-6.
1999: Brendan C Stack; T A Dalsaso; C Lee; Val J. Lowe; Paul D Hamilton; JW Fletcher; JA Fernandez-Pol
Overexpression of MPS antigens by squamous cell carcinomas of the head and neck: immunohistochemical and serological correlation with FDG positron emission tomography.
Anticancer research 1999;19(6C):5503-10.
1999: Val J. Lowe; H Kim; James H Boyd; J F Eisenbeis; Frank Dunphy; JW Fletcher
Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose PET imaging.
Radiology 1999;212(3):799-802.
1999: Brian T Collins; Val J. Lowe; Frank Dunphy
Correlation of CT-guided fine-needle aspiration biopsy of the liver with fluoride-18 fluorodeoxyglucose positron emission tomography in the assessment of metastatic hepatic abnormalities.
Diagnostic cytopathology 1999;21(1):39-42.
1999: R Edward Hogan; Val J. Lowe; Richard D Bucholz
Triple-technique (MR imaging, single-photon emission CT, and CT) coregistration for image-guided surgical evaluation of patients with intractable epilepsy.
AJNR. American journal of neuroradiology 1999;20(6):1054-8.
1999: M E Watson; Kathleen A Welsh-Bohmer; J M Hoffman; Val J. Lowe; D C Rubin
The neural basis of naming impairments in Alzheimer's disease revealed through positron emission tomography.
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists 1999;14(4):347-57.
1998: Brian T Collins; Laura J Gardner; A K Verma; Val J. Lowe; Frank Dunphy; James H Boyd
Correlation of fine needle aspiration biopsy and fluoride-18 fluorodeoxyglucose positron emission tomography in the assessment of locally recurrent and metastatic head and neck neoplasia.
Acta cytologica 1998;42(6):1325-9.
1998: H J Kim; J Boyd; Frank Dunphy; Val J. Lowe
F-18 FDG PET scan after radiotherapy for early-stage larynx cancer.
Clinical nuclear medicine 1998;23(11):750-2.
1998: Val J. Lowe; K S Naunheim
Current role of positron emission tomography in thoracic oncology.
Thorax 1998;53(8):703-12.
1998: Val J. Lowe; K S Naunheim
Positron emission tomography in lung cancer.
The Annals of thoracic surgery 1998;65(6):1821-9.
1998: Val J. Lowe; JW Fletcher; L Gobar; M Lawson; P Kirchner; P Valk; J Karis; Karl F Hubner; D Delbeke; E V Heiberg; E F Patz; R Edward Coleman
Prospective investigation of positron emission tomography in lung nodules.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):1075-84.
1997: Val J. Lowe; Frank Dunphy; Mark A Varvares; H Kim; M Wittry; Dunphy Cherie; Teresa L Dunleavy; EM McDonough; JR Minster; JW Fletcher; James H Boyd
Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography.
Head & neck 1997;19(8):666-74.
1997: Dunphy Cherie; Frank Dunphy; James H Boyd; Mark A Varvares; H J Kim; Val J. Lowe; Teresa L Dunleavy; J Rodriguez; EM McDonough; JR Minster
Expression of p53 protein in advanced head and neck squamous cell carcinoma before and after chemotherapy.
Archives of otolaryngology--head & neck surgery 1997;123(11):1223-5.
1997: Mary T Keogan; Val J. Lowe; M E Baker; VG McDermott; H K Lyerly; R Edward Coleman
Local recurrence of rectal cancer: evaluation with F-18 fluorodeoxyglucose PET imaging.
Abdominal imaging 1997;22(3):332-7.
1997: Val J. Lowe; Francis G Duhaylongsod; Edward F Patz; D M Delong; J M Hoffman; Walter G Wolfe; R E Coleman
Pulmonary abnormalities and PET data analysis: a retrospective study.
Radiology 1997;202(2):435-9.
1996: M E Hebert; Val J. Lowe; J M Hoffman; Edward F Patz; Mitchell S. Anscher
Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings.
American journal of clinical oncology 1996;19(4):416-21.
1996: JW Fletcher; Val J. Lowe
Is PET ready for prime time?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(6):948-9.
1995: Val J. Lowe; A G Bullard; R E Coleman
Ventilation/perfusion lung scan probability category distributions in university and community hospitals.
Clinical nuclear medicine 1995;20(12):1079-83.
1995: Edward F Patz; Val J. Lowe; Philip C Goodman; James Herndon
Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma.
Chest 1995;108(6):1617-21.
1995: Francis G Duhaylongsod; Val J. Lowe; Edward F Patz; A L Vaughn; R Edward Coleman; Walter G Wolfe
Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography.
The Annals of thoracic surgery 1995;60(5):1348-52.
1995: Francis G Duhaylongsod; Val J. Lowe; Edward F Patz; A L Vaughn; R Edward Coleman; Walter G Wolfe
Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
The Journal of thoracic and cardiovascular surgery 1995;110(1):130-9; discussion 139-40.
1995: Val J. Lowe; D M DeLong; J M Hoffman; R E Coleman
Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(5):883-7.
1994: Val J. Lowe; J M Hoffman; D M DeLong; Edward F Patz; R Edward Coleman
Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(11):1771-6.
1994: Val J. Lowe; J M Hoffman; Michael W Hanson; S Paine; E W Massey; L K Jordan; L Gray; Richard E Moon; R Edward Coleman
Cerebral imaging of decompression injury patients with 18-F-2-fluoro-2-deoxyglucose positron emission tomography.
Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 1994;21(2):103-13.
1994: Edward F Patz; Val J. Lowe; J M Hoffman; S S Paine; L K Harris; Philip C Goodman
Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.
Radiology 1994;191(2):379-82.
1993: Val J. Lowe; Kim L Greer; Michael W Hanson; Ronald J Jaszczak; R Edward Coleman
Cardiac phantom evaluation of simultaneously acquired dual-isotope rest thallium-201/stress technetium-99m SPECT images.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(11):1998-2006.
1993: Edward F Patz; Val J. Lowe; J M Hoffman; S S Paine; P Burrowes; R Edward Coleman; Philip C Goodman
Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.
Radiology 1993;188(2):487-90.